Nordic diltaizem trial (NORDIC)

From Aaushi
Jump to navigation Jump to search

Introduction

10,881 patients age 50-74 with diastolic BP > 100 mm Hg randomized, open, blinded endpoint study

Treatment groups

Endpoints: stroke, myocardial infarction, cardiovascular death

Analysis by intention to treat

Results:

More general terms

References

  1. Hannson L et al, Randomized trial of effects of calcium antagonists compared with diuretic and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study Lancet 2000; 356:359 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10972367